Patents Assigned to PATARA PHARMA, LLC
  • Publication number: 20180280341
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: April 19, 2018
    Publication date: October 4, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20180271828
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: April 19, 2018
    Publication date: September 27, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20180228762
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 16, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Pravin Soni, Robert Craig Armstrong
  • Publication number: 20180228761
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 16, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Pravin Soni, Ahmet Tutuncu
  • Publication number: 20180193305
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Application
    Filed: February 2, 2018
    Publication date: July 12, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20180193259
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Application
    Filed: February 2, 2018
    Publication date: July 12, 2018
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Ahmet Tutuncu, Pravin Soni
  • Patent number: 9968586
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: May 15, 2018
    Assignee: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 9962363
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: May 8, 2018
    Assignee: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20170273941
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: June 13, 2017
    Publication date: September 28, 2017
    Applicant: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 9707206
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided. Some embodiments relate to dosage forms. Dosage forms can include an aqueous pharmaceutical composition containing (i) from about 2% to about 6% by weight of cromolyn sodium, and (ii) an osmolarity adjusting agent consisting of (A) between about 0.1% to about 0.5% by weight of sodium chloride, inclusive of the endpoints, and (B) optionally salts of EDTA; and an inhalation device that forms an aerosol of said pharmaceutical composition, said aerosol exhibiting a respirable fraction of said pharmaceutical composition (<5 ?m) as measured by USP <1601> of at least about 60%, are provided.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: July 18, 2017
    Assignee: Patara Pharma, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 9265749
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: February 23, 2016
    Assignee: PATARA PHARMA, LLC
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni